Hiroshi Mikitani, Rakuten Medical CEO (Kiichiro Sato, AP Images)
Scoop: Rakuten Medical targets year-end close for $100M+ Series E to fund photoimmunotherapy pipeline: #Jefferies23
Rakuten Medical is aiming to close its Series E raise before the end of the year, with the funds designed to add fuel to its …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
